Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma
Clinical trial NCT06170151 · COMPLETED
Trial details
- NCT number
- NCT06170151
- Sponsor
- IRCCS San Raffaele
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-24
- Primary completion
- 2022-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.